These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5089336)

  • 21. [Amino-acid composition of some gram-positive and gram-negative bacteria].
    Sorokin PP
    Ukr Biokhim Zh; 1965; 37(2):239-42. PubMed ID: 4958124
    [No Abstract]   [Full Text] [Related]  

  • 22. [Penicillin-induced filamentous forms in Proteus vulgaris P 18 ].
    Fleck J; Mock M
    Ann Inst Pasteur (Paris); 1972 Sep; 123(3):319-32. PubMed ID: 4118184
    [No Abstract]   [Full Text] [Related]  

  • 23. [Structure of the fungal cell wall during prolonged exposure to visible light].
    Chebotarev LN; Zemlianukhin AA
    Mikrobiologiia; 1974; 43(5):853-6. PubMed ID: 4444558
    [No Abstract]   [Full Text] [Related]  

  • 24. Structural and serological studies of the lipopolysaccharide of Proteus vulgaris OX 19.
    Pardoe GI; Bird GW; Uhlenbruck G
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Dec; 136(5):488-96. PubMed ID: 4237338
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug resistance of Proteus vulgaris, Proteus morganii and Providencia rettgeri isolated from diagnostic specimens].
    Gołuszko P; Gospodarek E; Bugalski R
    Przegl Epidemiol; 1987; 41(3):319-23. PubMed ID: 3324173
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization, N-terminal sequencing and classification of cerein MRX1, a novel bacteriocin purified from a newly isolated bacterium: Bacillus cereus MRX1.
    Sebei S; Zendo T; Boudabous A; Nakayama J; Sonomoto K
    J Appl Microbiol; 2007 Nov; 103(5):1621-31. PubMed ID: 17953573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and partial amino acid sequence of thuricin S, a new anti-Listeria bacteriocin from Bacillus thuringiensis.
    Chehimi S; Delalande F; Sablé S; Hajlaoui MR; Van Dorsselaer A; Limam F; Pons AM
    Can J Microbiol; 2007 Feb; 53(2):284-90. PubMed ID: 17496978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical properties and the fine structure of proteocines.
    al-Jumaili IJ
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):421-32. PubMed ID: 983532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Typing of Proteus strains by proticine production and sensitivity.
    Senior BW
    J Med Microbiol; 1977 Feb; 10(1):7-17. PubMed ID: 320341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of new morganocin types of Morganella morganii in strains of diverse serotype and the apparent independence of bacteriocin type from serotype of strains.
    Senior BW; Vörös S
    J Med Microbiol; 1989 Jun; 29(2):89-93. PubMed ID: 2659799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological changes induced in listeria monocytogenes V7 by a bacteriocin produced by Pediococcus acidilactici.
    Heo S; Lee SK; Lee CH; Min SG; Park JS; Kim HY
    J Microbiol Biotechnol; 2007 Apr; 17(4):663-7. PubMed ID: 18051280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemical structure of mycobacterial cell wall].
    Petit JF
    Ann Microbiol (Paris); 1978 Jan; 129(1):39-48. PubMed ID: 350116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic and inhibiting effect of proteus].
    Kerasheva SI; Rakhtanova EP; Zvereva NM
    Antibiotiki; 1973 Mar; 18(3):236-9. PubMed ID: 4587462
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of desoxycholate on the activity of Proteus mirabilis phage receptors].
    Geuther R
    Z Allg Mikrobiol; 1969; 9(4):331-2. PubMed ID: 5365448
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic fractionation of calf thymus cell nucleus and characterization of water-insoluble lipoproteins.
    Tsumita T; Wada E
    Jpn J Exp Med; 1969 Oct; 39(5):519-26. PubMed ID: 5309563
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aspects of induced resistance to gentamicin in Proteus morganii and Escherichia coli].
    Nicoletti G; Castro A; Pisano A
    Antibiotica; 1968 Dec; 6(4):281-92. PubMed ID: 4906319
    [No Abstract]   [Full Text] [Related]  

  • 37. [Transmissible resistance to gentamicin and other aminoglycosidic antibiotics of Proteus morganii (author's transl)].
    Zikmundová V; Absolonová V; Krcméry V; Hustavová H
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):103-7. PubMed ID: 149603
    [No Abstract]   [Full Text] [Related]  

  • 38. [Identification and drug-susceptibility of Proteus group (author's transl)].
    Taira M; Ueda C; Shimabukuro A; Hokama S
    Rinsho Byori; 1979; 27(2):107-11. PubMed ID: 254702
    [No Abstract]   [Full Text] [Related]  

  • 39. "Triauxie" of Proteus morganii in amino acids supplemented medium and its enzymatic interpretation. I.
    BOURGEOIS S; WIAME JM; LELOUCHIER-DAGNELIE H
    Exp Cell Res; 1959 Aug; 18():167-8. PubMed ID: 13803319
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the "feedback control" of the synthesis of enzymes by amino acids during the growth of Proteus morganii].
    BOURGEOIS S; WIAME JM; LELOUCHIER-DAGNELIE H
    Biochim Biophys Acta; 1960 Feb; 38():136-44. PubMed ID: 13803320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.